COMMUNIQUÉS West-GlobeNewswire

IMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business
07/05/2024
FRANKLIN, Tenn., May 07, 2024 (GLOBE NEWSWIRE) -- On May 1, 2024, as previously announced, pursuant to that certain Settlement and Release Agreement, by and between IMAC Holdings, Inc. (NASDAQ: BACK) (“BACK”) and [...]
Femasys Expands Commercial Management Team with Addition of Experienced New Hires
07/05/2024
Team to Drive Strategic Initiatives, Launching Efforts at 2024 ACOG Meeting ATLANTA, May 07, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet [...]
Nanox to Participate in Three Upcoming Investor Conferences in May 2024
07/05/2024
PETACH TIKVA, Israel, May 07, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announces that Company management will [...]
Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference
07/05/2024
CAMBRIDGE, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today [...]
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy
07/05/2024
TARRYTOWN, New York, May 07, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica , Inc. (OTC: PXMD ), a biopharmaceutical company focused on advancing treatments for neurological disorders, provided a corporate update in [...]
BrightInsight Expands its Partnership with Google Cloud to Enhance the Patient Journey Through Generative AI
07/05/2024
BrightInsight is modernizing its development processes and patient companion apps with Google’s Gemini models, MedLM, and Vertex AI SAN JOSE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- BrightInsight, Inc, the trusted [...]
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
07/05/2024
WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet [...]
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
07/05/2024
The eAArly DETECT results reported a sensitivity for colorectal cancer of 97% with a specificity of 97% and a sensitivity for advanced adenoma of 82% BERKELEY, Calif. and MAINZ, Germany, May 07, 2024 (GLOBE NEWSWIRE [...]
Creyon Bio to Present Clinical Data on Rapid AI-Enabled Engineering of Oligonucleotide-Based Medicines at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
07/05/2024
AI-informed drug design enabled approval to dose within one year of project initiation Data highlight use of AI to engineer investigative allele selective antisense oligonucleotide treatment for baby with ultra-rare [...]
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
07/05/2024
Encouraging preliminary data announced from the NXP800 Phase 1b study in platinum resistant, ARID1a-mutated ovarian cancer, a program granted Fast Track Designation by the US FDA Data presented at the 2024 AACR [...]
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update
07/05/2024
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update Announced positive feedback from both FDA and EMA on the regulatory path for the Phase 3 program of the Nanobody ® [...]
Amolyt Pharma Announces Abstracts Accepted for Presentation at the GRS Congress, ECE and ENDO
07/05/2024
LYON, France and CAMBRIDGE, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced that the [...]
Amolyt Pharma dévoile les abstracts acceptés pour présentation aux congrès de la GRS, de l'ECE et de l'ENDO
07/05/2024
LYON, France et CAMBRIDGE, Mass., 07 mai 2024 (GLOBE NEWSWIRE) -- Amolyt Pharma, société spécialisée dans le développement de peptides thérapeutiques ciblant les maladies endocriniennes et métaboliques rares, a annoncé [...]
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
07/05/2024
Conference Call on Tuesday, May 14th, at 4:30 pm ET POMPANO BEACH, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading biotechnology company focused on the development, manufacture, [...]
Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy
07/05/2024
Investigational travatrelvir demonstrated preclinical activity against multiple SARS-CoV-2 variants Orally administered novel protease inhibitor does not require ritonavir co-administration First-in-Human study to [...]
Biora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate Update
07/05/2024
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced it will report financial results and provide a [...]
INmune Bio Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, May 9
07/05/2024
Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, May 07, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc . (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused [...]
Reflect Scientific Inc. Announces Second Quarter Sale of Groundbreaking Aerospace Manufacturing Solution
07/05/2024
OREM, Utah, May 07, 2024 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leading provider of innovative cooling solutions, today announced sales of $105,000 attributable to the successful launch of the [...]
PDS Biotech to Announce First Quarter 2024 Financial Results on May 15, 2024
07/05/2024
PRINCETON, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets [...]

Pages